1. Market Research
  2. > Pharmaceutical Market Trends
Protein A Resin Market

Protein A Resin Market

  • January 2020
  • 184 pages
  • ID: 5879093
  • Format: PDF
  • Prescient & Strategic Intelligence Private Limited


Table of Contents

Protein A Resin Market Research Report: By Source (Recombinant, Natural), Matrix (Agarose-Based, Glass or Silica-Based, Organic Polymer-Based), Application (Antibody Purification, Immunoprecipitation), End User (Biotechnology and Pharmaceutical Industries, Academic Institutes and Research Laboratories) – Industry Size, Share, Trends and Forecast to 2030

The major protein A resin market drivers are the increasing geriatric population, prevalence of chronic diseases, funding for protein research, and need to meet the need for therapies for various conditions. The market revenue is projected to surge to $1,020.7 million by 2030, from $486.4 million in 2019, at a 7.0% CAGR during the forecast period (2019–2030). Protein A resin is used as a separation medium during purification processes, such immunoprecipitation and chromatography. It separates biochemical mixtures based on the enzyme–substrate, antigen–antibody, and receptor–nucleic acid interactions.

Based on source, the protein A resin market is bifurcated into natural and recombinant, of which the recombinant bifurcation would display the higher CAGR, of 7.5%, during the forecast period. This is because recombinant protein A resins are heavily used during the production of monoclonal antibodies (mAb). Earlier, pharmaceutical companies did not pursue mAbs, owing to their stability, size, degradation rate, and delivery limitations. But, with increasing funding and focus of private and public institutions on protein-based research, the development of mAbs is picking up pace.

Across the world, the need for effective treatments for metabolic diseases, cardiovascular diseases, infectious diseases, and cancer is highly unmet. This is promoting the development of monoclonal antibodies, as they can function similar to the mediators involved in pathological processes. Additionally, mAbs and other therapeutic proteins are less toxic, highly effective and potent, safe, tolerable, selective, and chemically and biologically diverse, and they also do not accumulate much on tissues. Therefore, with the increase in the research and development (R&D) for mAbs, the usage of protein A resin would rise.

The application segment of the market also has two bifurcations — antibody purification and immunoprecipitation — of which antibody purification held the larger share in 2019 and it would also grow faster during the forecast period, at a 7.2% CAGR. Similarly, of the two bifurcations within the end user segment — academic institutes & research laboratories and biotechnology & pharmaceutical industries — the latter dominated the protein A resin market in 2019, with a 91.6% value share. This end user consumes the biomaterial in huge amounts to produce mAbs.

One of the primary reasons behind the rising demand for monoclonal antibodies is the increasing incidence of chronic diseases. mAbs display a suitable pharmacokinetic profile, their solubility can be customized, and they also have a lesser chance of inducing an immune response, which is essential for the treatment to work. The diseases caused by hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human papillomavirus (HPV) are increasing in prevalence, due to the low accessibility of healthcare in developing nations.

As per the Joint United Nations Program on HIV and AIDS (UNAIDS), 36.9 million had HIV in 2017. Similarly, as per the data jointly published by the American Stroke Association (ASA) and American Heart Association (AHA), heart diseases killed 836,546 people in the U.S. in 2018. Further, the World Health Organization (WHO) estimates the number of cancer cases, expected to be diagnosed in 2030, at 21.4 million. Thus, the rising prevalence of such diseases will lead to a surging demand for mAbs, thereby driving the protein A resin market advance.

Geographically, North America led the market in 2019, with a share of 37.4%, owing to the increasing requirement for protein therapeutics for chronic diseases and rising number of biopharmaceuticals with the Food and Drug Administration’s approval. During the forecast period, Asia-Pacific (APAC) would observe the fastest progress in the protein A resin market during the forecast period, at a 7.8% CAGR. This would be because of the rising usage of such biomaterial in drug research, technological advancements, growing pharmaceutical sector, and surging demand for vaccines and other therapeutics.

Therefore, with the increasing R&D for drugs and disease treatment, especially for monoclonal antibodies, the consumption of protein A resin would also escalate.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

  • $ 2600
  • October 2021
  • 433 pages

Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective This report provides you with a landscape ...

  • World
  • Pharmaceutical
  • Biopharmaceutical
  • Industry analysis
  • Number Of Employees
  • Hospital Admission


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on